US 7795389
Antagonizing TGF-beta activity with various ectodomains TGF-beta receptors used in combination or as fusion proteins
granted A61KA61K38/00
Quick answer
US patent 7795389 (Antagonizing TGF-beta activity with various ectodomains TGF-beta receptors used in combination or as fusion proteins) held by The Board of Regents of the University of Texas System expires Mon Sep 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Sep 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K38/00